Pfizer ne želi da FDA objavi "poverljive podatke" o njihovoj vakcini.Pfizer Inc wants to intervene in a Texas federal lawsuit seeking information from the U.S. Food and Drug Administration used in licensing the company's COVID-19 vaccine, a litigation move that plaintiffs who are suing for the data say is premature.
Pfizer's lawyers at DLA Piper told U.S. District Judge Mark Pittman on Jan. 21 it wanted a role in the proceedings to help the FDA avoid "inappropriately" disclosing trade secret and confidential commercial information.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
Moderna u NEJM-u objavila da i trećoj dozi sa vremenom značajno opada mogućnost neutralizacije omikrona. Kao i Pfizer, započeli su kliničko ispitivanje vakcine prilagođene omikronu.Neutralization titers against the omicron variant 6 months after the third (booster) dose of vaccine were 6.3 times lower than the peak titers assessed 1 month after the booster injection, but the titers remained detectable in all the participants